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ABSTRACT 
 
Antimicrobial drug resistance is increasing worldwide at a frightening rate and is found 
among different species of bacteria causing nosocomial and community-acquired 
infections.  Carbapenem-resistant Enterobacteriaceae (CRE’s) are one of the multi-drug 
resistant bacteria increasingly reported in the past decade, leaving the health care system 
unable to control the spread of antibiotic-resistant infections.  A rapid and efficient 
method to identify drug resistant bacteria could advance the containment of this scourge.  
  
We thus investigated the use of MALDI-TOF MS technology, recognized as an accurate 
method for microorganism identification, as a potential tool for the detection of CRE 
based on the protein profiling for specific fingerprints.  
 
From 24 hours sub-cultured bacterial isolates known to carry and/or express single genes 
of a variety of carbapenemases, proteins were extracted using the formic acid ethanol 
extraction method and subjected to MS-based identification by MALDI-TOF MS 
Biotyper technology.  The mass spectrometry spectra were then analyzed employing the 
programmed software flexAnalysis version 3.4 build 70 and ClinProTools version 2.2 
build 83 to detect carbapenemases.  The spectra were subjected to visual inspection for 
specific peaks characterization. 
 
Despite their close relationship, the method was able to differentiate between CRE and 
susceptible bacteria.  The differences within carbapenemases were better distinguishable 
by visual observation of specific biomarker peaks and the modified main spectrum (MSP) 
method demonstrated that these differences could be more obvious by focusing on 
matchless low intensity peaks.  
 
Although the differentiation of CRE remains a challenge using MALDI Biotyper MS 
based on the protein profiling, according to our data and pending further investigation in 
clinical isolates of CRE, MALDI-TOF MS has potential as a diagnostic tool for the rapid 
detection of these multi-drug resistant bacteria. 
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CHAPTER 1 
1 INTRODUCTION 
In order to honor the title of this chapter, emphasis will be placed briefly on carbapenem-
resistant bacteria.  They have increased considerably in prevalence and incidence, 
appearing rapidly in several countries.  Genes that encode them have jumped the species 
barrier.  This work will thus focus on aspects of carbapenem-resistance 
enterobacteriaceae (CRE), including all reported classes of carbapenem hydrolyzing 
enzymes, then the application of mass spectrometry technology for the rapid diagnosis of 
these microorganisms.  
 
1.1 CARBAPENEM-RESISTANT ENTEROBACTERIACEAE 
Enterobacteriaceae are inhabitants of gastrointestinal flora and represent the most 
common of human pathogens, being responsible for several infections, such as cystitis 
and pyelonephritis with fever (Katsuta, Shoji, Watanabe, & Saitoh, 2013), septicaemia 
(Nordmann, Naas, & Poirel, 2011), pneumonia (von, Welte, Marre, Suttorp, & Ewig, 
2010), peritonitis, meningitis and device associated infections (Andrade, et al., 2010).  
They are the cause of infections acquired in the community and hospitals, with the 
tendency to spread between humans and to obtain genetic material through horizontal 
gene transfer, intermediated by plasmids and transposons (Partridge, 2011; Toleman & 
Walsh, 2011).  Due to the increased use and misuse of antibiotics, enterobacteriaceae 
have developed resistance to numerous antibiotics such as carbapenem class.  
Antimicrobial resistance is the focus of global attention and CRE pose the latest 
challenge in gram-negative bacterial infections (Gupta, Limbago, Patel, & Kallen, 2011).  
CRE have been reported worldwide, as a result of acquiring carbapenemase genes, 
making it difficult the control of the spread of contagion.  Thereby CRE have created a 
global public health problem, for the infections caused by this resistant bacteria often fail 
to respond to the standard treatment, resulting in prolonged illness and greater risk of 
death. 
 
In view of the difficulty of mastering these infections, faster susceptibility profiling is 
imperative for the early diagnosis, and containment of carbapenem resistance.  
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Furthermore rapid and efficient detection of carbapenemase production in clinical isolates 
is imperative to prevent the spread of drug resistance-associated deaths through early 
diagnosis of the causative organism.  However, the detection methods for carbapenemase 
producers remain a challenge.   
 
Currently, various methods are employed to detect carbapenemases.  Most of these 
methods are phenotypic, such as E-test (Jorgensen & Ferraro, 2009), modified Hodge test 
(MHT) (Amjad, et al., 2011; K. Lee, et al., 2010), 3-dimensional extract (3-D) bioassay 
(Montealegre, et al., 2012), Carbapenemase Nordmann-Poirel test (Carba NP test) 
(Nordmann, Poirel, & Dortet, 2012), spectrophotometry-based assay (Bernabeu, Poirel, 
& Nordmann, 2012), and DNA-based tests (Xia, Liang, Su, & Xiong, 2012).  The E-test 
and MHT are simpler to perform and have been widely used as screening methods but are 
phenotypic and unable to detect the presence of silent or poorly expressed carbapenemase 
genes.  The limits of MHT, E-test and 3-D bioassay are that they time consuming because 
of the incubation duration and results are sometime difficult to interpret (K. Lee, et al., 
2010).  Spectrophotometric measurement is considered to be the reference method for the 
detection of carbapenemase production, but it is labor intensive and requires relatively 
skilled technical expertise (Bernabeu, et al., 2012).  The Carba NP test is a biochemical 
method developed recently that uses a pH indicator for the detection of carbapenemase 
production, and is yet to be evaluated for some bacteria such as Acinetobacter spp. and it 
too is phenotypic (Dortet, Poirel, & Nordmann, 2012a, 2012b; Nordmann & Poirel, 
2013).  Polymerase chain reaction (PCR) of carbapenemase genes remains the gold 
standard and although reliable, it is more expensive, requires sophisticated equipment and 
a higher degree of expertise (Poirel, Walsh, Cuvillier, & Nordmann, 2011). 
 
Four decades ago mass spectrometry (MS) has been applied to identify microorganisms 
(Anhalt & Fenselau, 1975; Bizzini, Durussel, Bille, Greub, & Prod'hom, 2010) and it has 
also proven its broad applicability in clinical epidemiology and infection control 
measures such as highlighting the dissemination of pathogens, in medical diagnostics, 
bio-defense, environmental monitoring, and food quality control.  This study will use 
mass spectrometry technology specifically MALDI-TOF MS which is relatively simpler, 
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accurate, rapid and with lower consumable costs (Seng, et al., 2009), to address the above 
global problem.  
 
1.2 MASS SPECTROMETRY  
Mass spectrometry is a qualitative and quantitative analytical method employed to reveal 
the composition of an unknown sample (Wieser, Schneider, Jung, & Schubert, 2012).  
Using this technology, trace amounts of material can be analysed to identify a specific 
molecule, in some cases where it is located and how much of the molecule is expressed.  
The principle of mass spectrometry is based on the acquisition and analysis of mass and 
charge values from individual ionized sample molecules (Kafka, Kleffmann, Rades, & 
McDowell, 2011).  Mass spectrometry instruments consist of three components: the 
ionization chamber, the mass analyser and an ion detector.  The unknown sample is 
pulsed in the ionization chamber with an energy source, and can be in difference phases 
such as in gas, liquid or solid.  The energy serves a double function, these being 
ionization of individual molecules, and the desorption of solid or liquid samples into the 
gas phase.  The vaporized sample is then focused and accelerated through the mass 
analyser component that separates ions based on their mass to charge ratio.  Acceleration 
of the charged atoms is achieved by applying a large voltage (Banerjee & Mazumdar, 
2012).  Upon emerging from the mass analyser, ionized elements bump with the ion 
detector, which measures both the mass and charge of each molecule as derived from 
their individual force and time to impact.  These signals are converted to an electrical 
output and illustrated in a mass spectrum, which graphs the relative abundance of each 
detected ion on the y-axis plotted against its mass-to-charge ratio on the x-axis.  The 
composition or structure of the unknown sample is subsequently derived from cautious 
interpretation and analysis of the ion peaks (El-Aneed, Cohen, & Banoub, 2009).   
 
Various mass spectrometry instruments are available, and are differentiated firstly by 
their method of sample ionization and secondly by the type of mass analyser used.  The 
choice of instrument is based on the phase of the input sample, then on the physical and 
chemical properties of the analytics, such as their molecular weight, thermal stability and 
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side-chain modifications (Glish & Vachet, 2003). 
 
Mass spectrometry technology was initially largely limited to the analysis of small, 
thermo-stable compounds that were able to support the harsh electric ionization 
techniques available at the time, and was not widely considered for routine applications 
in biological sciences.  Larger polypeptides and other biomolecules were found to rapidly 
degrade under these conditions, which significantly hampered their characterization.  In 
the past decade, with the beginning of the proteomics era, however, research into 
alternative mass spectrometry methods was accelerated, and resulted in the development 
of low energy or soft ionization techniques, such as electrospray mass spectrometry and 
Matrix Assisted Laser Desorption Ionization Time of Flight Mass Spectrometry 
(MALDI-TOF MS) (Banerjee & Mazumdar, 2012).  The major advantage of this method 
is its ability to ionize and desorb high molecular weight biomolecules into the gas phase, 
while preserving their intact state.  Based on these general considerations, MALDI-TOF 
MS is used today as one of the most powerful tools to analyse and identify large 
polypeptides as well as whole microorganisms (Pavlovic, Huber, Konrad, & Busch, 
2013; Pulcrano, et al., 2013; Webster & Oxley, 2012).   
 
1.2.1 PRINCIPLES OF MALDI-TOF MS  
The composition of the samples identified by the MALDI-TOF MS can vary greatly, 
from purified protein to whole-cell microorganisms.  Unknown sample characterization 
occurs in three stages, beginning with sample preparation, followed by spotting on a solid 
target support plate, and lastly by being overlaid with a chemical matrix, depending on 
the composition, which must dry completely prior to analysis (El-Aneed, et al., 2009).  
The matrix is essential for the soft ionization process, and is selected for both its ability to 
effectively absorb the majority of pulsed ionizing energy, and its efficient desorption into 
the gas phase, thus protecting sample molecules from fragmentation.  A number of 
matrices have been established and are each composed of small (<1000 Dalton), acidic 
molecules dissolved in an organic solvent.  An approximate 10 to 1 ratio of matrix to 
sample is used for MALDI-TOF MS preparation to ensure the efficient dilution and 
protection of sample molecules from fragmentation.  Once dried, the prepared target plate 
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is engaged into the ionization chamber, where each sample is irradiated with brief pulses 
of laser energy (in case of our Bruker instrument, 240 pulses are used from an ultraviolet 
nitrogen laser 337 nm).  This process desorbs individual sample and matrix molecules 
from the target plate into a gas phase, with most of the energy being captivated by the 
matrix, which becomes ionized with a single positive charge.  This positive charge is 
subsequently relocated from the matrix to native sample proteins through their arbitrary 
collision in the gas phase. 
 
 
Figure 1. MALDI-TOF MS process (Elitza S. Theel, 2013) 
 
MALDI-TOF MS has recently been initiated into routine laboratory methods as a novel 
approach for the accurate and rapid identification of bacteria, fungi and yeast (Jurinke, 
Oeth, & Van, 2004; Wieser, et al., 2012).  This equipment generates distinctive unique 
signatures mass spectral fingerprints for each microorganism, and is therefore perfect for 
precise microbial identification at the genus and species levels.  This method has the 
prospect of being expended for strain typing and identification with numerous successful 
reports on clinical isolates of bacteria (Patrick R. Murray, 2012).  MALDI-TOF MS has 
also been used to demonstrate the diagnosis of some diseases such as tumours, 
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rheumatoid arthritis, and Alzheimer’s disease, through the characterization of particular 
biochemical markers (Marvin, Roberts, & Fay, 2003; Schoene, Hoefler, & Walch, 2013).  
While several studies have described the use of this method as a rapid detection tool for 
drug resistant bacteria, such as CRE, they were more focused on detecting the drug and 
their degradation products (Burckhardt & Zimmermann, 2011; Hrabak, et al., 2012; 
Sparbier, Schubert, Weller, Boogen, & Kostrzewa, 2012; L. Wang, Han, Sui, Wang, & 
Lu, 2013). 
 
1.3 PROBLEM STATEMENT 
MALDI-TOF MS has been tested for speed and accuracy on microorganisms for their 
identification at species and genus level, also for carbapenem resistant bacteria detection 
focusing on the characterisation of the drug and their degradation product, but no studies 
have been done to establish whether it can accurately and rapidly detect CRE based on 
protein profiling.  The purpose of this study is therefore to apply MALDI-TOF mass 
spectrometry technology to accurately and rapidly diagnose drug resistant bacteria, such 
as CRE by characterisation of their protein profile.  This will allow clinicians to 
accurately identify the identity and putative susceptibility profile of the causative bacteria 
informing the clinical management of the infection timeously. 
 
1.4 AIM AND OBJECTIVES 
The aim was to investigate the efficiency of MALDI-TOF MS as an accurate and rapid 
method to detect carbapenemase-producing bacteria. 
The objective was to identify CRE based on rapid protein profiling for specific 
fingerprints using MALDI-TOF mass spectrometry. 
 
1.5 CLASSIFICATION OF CABAPENEM HYDROLYSING ENZYMES 
Not metalloenzyme carbapenemase (NMC-A) was identified in 1993 as the first class A 
carbapenemase produced by enterobacteriaceae (Naas & Nordmann, 1994), after which  
numerous others were identified in enterobacteriaceae belonging to three classes, these 
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being Ambler class A, B, and D beta-lactamases.  In addition Ambler class C generated 
by enterobacteriaceae may possess slight extended action toward carbapenems, although 
the clinical role of this class remains unknown. 
 
1.5.1 AMBLER CLASS A CARBAPENEMASES  
The Ambler class A serine carbapenemases can be broadly divided into subgroups based 
on phylogenetic data that include Guiana extend spectrum (GES), not metalloenzyme 
carbapenemase (NMC-A), Klebsiella pneumoniae carbapenamase (KPC), Imipenem 
hydrolysing beta-lactamase (IMI) and Serratia marcescens carbapenemase (SME).  
These enzymes have been identified in Enterobacter cloacae, Serratia marcescens and 
Klebsiella pneumoniae (Nordmann, Naas, et al., 2011).  The clinically most important 
subgroup is the gradually emerging KPC enzymes (Nordmann, Picazo, et al., 2011).  The 
gene that controls their production can be situated on the bacterial plasmid or the 
chromosome.  KPC producers are generally multidrug resistant, and curative options for 
treating KPC related infections remain restricted (Nordmann, Cuzon, & Naas, 2009) as 
do rapid and efficient tools for their diagnosis (Birgy, et al., 2012).  
 
1.5.2  AMBLER CLASS B CARBAPENEMASES  
Metallo-beta-lactamases (MBLs), known as Ambler class B carbapenemases, contain 
zinc in their active sites.  The enzymes Verona integron-encoded metallo-beta-lactamase 
(VIM), active on Imipenem (IMP), and New Delhi metallo-beta-lactamase (NDM) are 
members of this group.  The subtype most widely disseminated was VIM (Queenan & 
Bush, 2007), and it was recently found that NDM-1 has spread worldwide, after initially 
only presenting in  Asia, in enterobacteriaceae and in the other gram-negative bacteria.  
The recurrent association of this resistant gene with a promiscuous plasmid enhances its 
proliferation (Nordmann, Poirel, Toleman, & Walsh, 2011; Yong, et al., 2009). 
 
1.5.3 AMPC β -LACTAMASE 
Numerous AmpC enzymes have an intrinsic but very weak ability to hydrolyse 
carbapenems.  The first bacterial enzyme reported to destroy penicillin was the AmpC 
	   8	  
beta-lactamase of Escherichia coli (Abraham & Chain, 1988), which belongs to the 
Ambler class C.  In P. aeruginosa and in enterobacteriaceae, the genes responsible for 
the production of AmpC beta-lactamase can be located on the bacterial plasmids or 
chromosomes.  The AmpC genes located on plasmids constitutively produce beta-
lactamases, but they have slight activity against some classes of drugs, such as 
carbapenems and monobactam (aztreonam).  However, once it is combined with reduced 
susceptibility due to efflux and porin mechanisms, clinically significant levels of 
resistance are accomplished (Marsik & Nambiar, 2011). 
 
1.5.4 AMBLER CLASS D CARBAPENEMASES 
The group of class D is of the oxacillinase (OXA) enzyme type, which is a penicillinase 
capable of hydrolysing oxacillin and cloxacillin.  They present feeble activity against 
carbapenems, and are primarily found in Acinetobacter baumannii, Pseudomonas 
aeruginosa, but rarely in Enterobacteriaceae.  The location of these genes can be on 
bacterial plasmids or chromosomes (Mendes, Bell, Turnidge, Castanheira, & Jones, 
2009).  Activity of OXA carbapenemases can be increased by upstream elements that 
control gene expression.  The main concern regarding OXA carbapenemases is their 
ability to rapidly mutate and enlarge their spectrum of activity (Queenan & Bush, 2007).  
 
Table 1: Group of carbapenemases and AmpC beta-lactamases within β-lactamases 
classification (Marsik & Nambiar, 2011). 
 Ambler group 
A B C D 
Bush-Jacoby 
group 
 2f 3a 1 2df 



























Sub-type example KPC, GES, SME IMP, NDM, VIM, IND AmpC OXA 
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1.6 CURRENT THERAPEUTIC OPTIONS FOR TREATMENT OF BACTERIAL INFECTION BY 
CRES 
The optimal treatment of infection due to carbapenemase producing organisms is 
uncertain, and antibiotic options are limited.  The presence of KPC or metalloenzyme 
carbapenemase confers resistance to all penicillins, cephalosporins, and carbapenems 
(Arnold, et al., 2011).  Due to the spread of carbapenemase producing bacteria, clinicians 
are becoming progressively dependent on colistin, polymyxins, aztreonan, fosfomycin, 
tigecycline and rifampicin for treatment of these infections (J. Lee, Patel, Huprikar, 
Calfee, & Jenkins, 2009; Livermore, et al., 2011; Zavascki, et al., 2006).  Some experts 
reported that high-dose continuous infusion of a carbapenem might be helpful, although 
clear evidence of efficacy is lacking (Sakka, et al., 2007).  There is a need for information 
concerning the optimal use of these antibiotics with or without other partially active 
antibiotics in the treatment of infections caused by carbapenemase producing bacteria. 
 
Available beta-lactamase inhibitors, for example clavulanic acid, can restore activity of 
beta-lactams in vitro against carbapenemase producing bacteria, but such additions do not 
lower the MIC values of beta-lactam antibiotics to within the susceptible range and 
should not be used (Stachyra, et al., 2009).  A novel beta-lactamase inhibitor (NXL104) 
is presently in development and has activity against the KPC enzyme (Livermore, 
Mushtaq, Warner, Miossec, & Woodford, 2008; Stachyra, et al., 2009), and an emphasis 
should therefore be also placed on the identification of new and innovative tool for 
diagnostic as well discovery of news beta-lactamases inhibitors.   
 
Various methods are currently used to detect carbapenemases, most of them being 
phenotypic.  Current methods used for bacterial identification and for drug susceptibility 
profile requires at least two days, or more for fastidious organisms.  In addition, 
differentiation of isolates with a different taxonomic background but similar 
physiological characteristics is limited using these phenotypic methods.  MALDI-TOF 
MS requires only overnight culture of bacteria.  Reliable data are available within a total 
turnaround time of 16 hours.  Due to short turnaround times, low sample volume 
requirements and low reagent costs, MALDI-TOF MS has recently emerged as a 
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powerful tool for the identification of clinical isolates. (Amjad, et al., 2011; Bernabeu, et 
al., 2012; Jorgensen & Ferraro, 2009; Montealegre, et al., 2012; Nordmann, et al., 2012). 
 
1.7 OUTLINE OF THE THESIS 
This project evaluated the potential of MALDI-TOF MS as a rapid and accurate detection 
tool for CRE producing different carbapenemases.  Chapter 2 outlines the use of this tool 
to identify carbapenemase producing Escherichia coli. Chapter 3 reviews the 
characterisation of carbapenemase produced by different bacteria, such as K. 
pneumoniae, S. marcescens, E. cloacae.  Chapter 4 presents the limitations and 
recommendations, establishes to what extent the aim was achieved, and indicates the 
significance of the study.   
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CHAPTER 2 
Rapid detection of carbapenemase-producing Escherichia coli using Matrix Assisted 
Laser Desorption Ionization Time of Flight Mass Spectrometry (MALDI-TOF MS) 
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ABSTRACT 
The method of direct mass spectrometry profiling is reliable and reproducible for the 
rapid identification of clinical isolates of bacteria and fungi.  This study used the 
approach of MALDI-TOF mass spectrometry profiling for carbapenem-resistant 
enterobacteriaceae (CRE), specifically the identification of carbapenemase-producing 
Escherichia coli.  Proteins were extracted from sub-cultured E. coli isolates known to 
carry and/or express single genes of a variety of carbapenemases and subjected to mass 
identification by MALDI-TOF MS Biotyper technology.  The confidence score 
exceeding 2.3 suggested high quality of mass spectra and high significance of the data 
obtained.  The MS spectra were subjected to visual peak picking and in all cases, there 
were significant differences in the presence or absence of peaks to differentiate isolates 
expressing different carbapenemases.  The Biotyper MSP creation method and 
identification method could be optimized to provide a significantly high difference in 
score between E. coli expressing different carbapenemases.  Based on our data and 
pending further investigation in other CREs, MALDI-TOF MS has potential as a 
diagnostic tool for the rapid detection of even closely related carbapenemases in E. coli. 
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1 INTRODUCTION 
Antimicrobial resistance is the focus of global attention and carbapenem-resistant 
enterobacteriaceae (CREs) pose the latest challenge in gram-negative bacterial infections 
(Burckhardt & Zimmermann, 2011).  The rapid and efficient detection of carbapenemase-
production by clinical isolates is important to prevent drug resistance- associated deaths 
with early diagnosis of the causative organism as well as its susceptibility profile being 
imperative for the implementation of efficacious treatment as soon as possible 
(Nordmann, et al., 2012).  However, the detection methods for carbapenemase producers 
remain a challenge.  Currently, various methods are employed to detect carbapenemase 
and most of them are phenotypic, such as the minimum inhibitory concentration E-test 
(Jorgensen & Ferraro, 2009), modified Hodge test (MHT) (Amjad, et al., 2011; K. Lee, et 
al., 2010), 3-dimensional extract (3-D) bioassay (Montealegre, et al., 2012), 
Carbapenemase Nordmann-Poirel test (Carba NP test) (Nordmann, et al., 2012), 
spectrophotometry-based assay (Bernabeu, et al., 2012), and DNA-based tests (Xia, et al., 
2012).  The E-test and MHT are simpler to perform and have been widely used as 
screening methods.  The MHT, E-test and 3-D bioassay are time consuming because of 
the incubation duration and the results can be difficult to interpret (K. Lee, et al., 2010).  
Spectrophotometric measurement is considered to be the reference method for the 
detection of carbapenemase production, but it is labor intensive and requires relatively 
skilled technical expertise (Bernabeu, et al., 2012).  The Carba NP test is a biochemical 
method developed recently that uses a pH indicator for the detection of carbapenemase 
production, and is yet to be evaluated for some bacteria such as Acinetobacter spp. 
(Dortet, et al., 2012a, 2012b; Nordmann & Poirel, 2013).  Polymerase chain reaction 
(PCR) of carbapenemase genes remains the gold standard and although reliable, it is 
more expensive and requires sophisticated equipment and a higher degree of expertise 
(Poirel, et al., 2011). 
 
Over the last few years matrix assisted laser desorption ionization time of flight mass 
spectrometry (MALDI-TOF MS) has been recognized as a powerful tool for the 
identification of bacteria and yeasts in many clinical diagnostic laboratories (Bizzini, et 
al., 2010; Lindsay G. Stevenson, Steven K. Drake, & Murray, 2010; Seng, et al., 2009; 
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Stevenson, Drake, Shea, Zelazny, & Murray, 2010; van, Claas, & Kuijper, 2010; Wieser, 
et al., 2012).  Spectral profiles obtained by MALDI-TOF MS are highly selective for 
each bacterial species, resulting in specific fingerprints that allow the differentiation at 
the genus, species and even strains levels (Bailey, et al., 2013; Balada-Llasat, Kamboj, & 
Pancholi, 2013; Marvin, et al., 2003; Wieser, et al., 2012).  This method involves the 
desorption and ionization (thus the "D" and the "I" in the name MALDI) of individual 
proteins and other molecules that allow the resulting ions (typically singly charged) to be 
separated by the time-of-flight (TOF) analyzer and detected by the multichannel plate 
(MCP) or similar detector (Kafka, et al., 2011).  MALDI-TOF MS has been evaluated by 
several investigators for the identification of carbapenemases, generally based on the 
detection of carbapenem drugs and their degradation products.  They concluded that mass 
spectrometry is a useful tool for determining carbapenemase activity but was not able to 
differentiate between the carbapenemases expressed. (Burckhardt & Zimmermann, 2011; 
Hrabak, et al., 2012; Kempf, et al., 2012; W. Lee, et al., 2013).   
 
Studies focusing on the protein MS profiling to identify antimicrobial resistance have 
also been published, such as for methicillin resistant staphylococcus aureus (MRSA) 
(Kornienko, et al., 2012; Y. R. Wang, Chen, Cui, & Li, 2013), which can be applied to 
the MALDI Biotyper as a conventional method for biotyping of drug susceptibility.  
Elucidation of mass spectra obtained by the method of direct MS profiling can consider 
not only species identity but also strain specificity of the analyzed mass spectra of E. coli, 
as different strains carry various virulence and pathogenicity factors.  Since most 
virulence and pathogenicity factors are characterized by larger molecular masses than MS 
detection limits (Plata, Rosato, & Wegrzyn, 2009), we postulated that proteins may 
undergo some modifications during sample preparation. 
 
The MALDI-TOF MS approach is relatively simple, rapid and reliable data are available 
within a total turnaround time of 16 hours also cost-effective method with significantly 
lower consumable compared to the current identification approaches (Pavlovic, et al., 
2013; Seng, et al., 2009).  The purpose of this study was to evaluate the potential of 
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developing MALDI-TOF MS as a rapid method to differentiate between Escherichia coli 
producing different carbapenemases. 
 
2 MATERIALS AND METHODS   
3.1 BACTERIAL ISOLATES  
E. coli isolates expressing seven different carbapenemases enzymes (KPC-2, VIM-1, 
VIM-2, NDM-1, NDM-4, IMP-1, and OXA-48) belonging to the molecular classes A, B 
and D were purchased from France (Institut National de la Santé et de la Recherche 
Médicale, Paris, France).  This group had previously characterized these isolates for their 
beta-lactamase content at molecular level (Nordmann, et al., 2012), and susceptibility test 
have been carried out for all the strains used in this study by our group prior to go for 
MALDI approach.  Disc diffusion and broth dilution methods according clinical 
laboratory standard institute (CLSI) guidelines were followed for this experiment.  E. coli 
ATCC (American Type Culture Collection) 25922 was used as drug susceptible strain in 
each set of tests for control.  The designations (e.g. IMP-1) used here represent different 
classes of carbapenemases enzymes.  All isolates were stored at -80 °C in tryptic soy 
broth with 10% glycerol and recovered at 37 °C in Nutrient Agar medium prior to use.  
Primary sub-cultures were used for MALDI-TOF MS analysis. 
 
3.2 PREPARATION OF THE INTACT BACTERIAL CELL  
All isolates were sub-cultured in Nutrient Agar medium (OXOID England) at 37 °C for 
24 h.  Fresh bacterial cells were transferred into protein LoBind tubes (eppendorf, 
Germany) containing sterile MilliQ water which was adjusted to an optical density of 
OD600 = 0.8, then 300 µL of this dilution was pipetted into a new eppendorf tubes and 
mixed with 900 µL of 100% ethanol (HPLC grade, Sigma Aldrich Germany).  The 
mixture was centrifuged at 13000 rpm for 2 minutes; the supernatant was decanted and 
centrifuged once again to remove the ethanol completely.  The pellet was re-suspended in 
50 µL of 70% formic acid and 50 µL of acetonitrile mixed carefully and centrifuged at 
13000 rpm for 2 minutes.  An aliquot of 1 µL of the supernatant (intact bacterial cells) 
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was applied in duplicate directly onto a cell of the MSP 96 target polished steel plate 
(Bruker Daltonics, Germany).  After drying for 1-2 minutes, 1 µL of the saturated matrix 
solution containing acetonitrile, trifluoroacetic acid and MilliQ water (HPLC grade 
respectively) with α-4-cyano-hydroxycinnamic acid (Bruker Daltonics, Germany) was 
applied onto the sample.  The prepared target was air dried prior to MALDI-TOF MS 
analysis.  Mass spectra were acquired in duplicate batches for each isolate. The same 
experiment has been repeated the following day for the reputability test. 
 
3.3 MASS SPECTROMETRY TESTS    
Mass spectra were acquired using a MALDI-TOF mass spectrometer (Bruker Daltonics) 
equipped with the nitrogen laser.  Spectra were registered in the linear mode of positive 
ions (20 kV) in the range of molecular masses 2000-20000 Dalton (Da).  Bruker Bacterial 
Test Standard (BTS) obtained from Bruker Daltonics Germany containing a carefully 
manufactured extract of E. coli DH5 alpha with two additional proteins that extend the 
upper boundary of the mass range covered by BTS was selected as calibration standard 
for the instrument.  The increase of detection sensitivity was achieved by matrix excess 
removal by 6 laser impulses at 40% power output followed by subsequent data 
acquisition at laser power from 30-40%.  Each spectrum was acquired with 240 laser 
impulses (40 impulses with various spot points).  The spectra with resolution exceeding 
400 were acquired.  The programmed software (flexControl version 3.4 build 119, 
flexAnalysis version 3.4 build 70 and ClinProTools version 2.2 build 83) was employed 
for acquiring, treatment, and analysis of mass spectra for differentiation of isolates at the 
strain level to differentiate drug resistant strains from the susceptible one investigated.  
This clustering version of mass spectra is an approach based on the use of algorithms of 
the ClinProTools software, which was initially developed for search of protein markers of 
various oncological diseases (Ketterlinus, Hsieh, Teng, Lee, & Pusch, 2005; Qiu, et al., 
2009).  Identification was performed using the MALDI Biotyper 3.1 software (Bruker 
Daltonics) by comparing experimental spectra with the reference library of the database 
containing 4613 spectra of various microorganisms.  Mean spectra (MSP) was created by 
importing two suitable spectra into the MALDI Biotyper software to include all the peaks 
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that were identified as exclusive between the species.  More details about the exact 
settings chosen are presented in the results section.  Species identification was considered 
reliable, when the score calculated exceeded 2.300.  The score from 2.000 to 2.299 
provided reliable genus identification only (Table 1). 
 
Table 1. Biotyper score range and interpretation of values proposed by the manufacturer (Bruker 
Daltonics) 
Range Description 
2.300-3.000 Highly probable species identification 
2.000-2.299 Secure genus identification, probable species identification 
1.700-1.999 Probable genus identification 
0.000-1.699 Not reliable identification 
 
3 RESULTS    
3.1 ANALYSIS OF MASS SPECTROMETRY DATA    
Primary bacteriological species identification of all selected E. coli (Nordmann, et al., 
2012) was confirmed by MALDI-TOF MS profiling.  The experiments were reputable 
and reproducible so well correlated.  The database was reliable in identifying the E. coli 
species with the confident score of 2.4 to 2.5 when the standard methods for MSP 
creation and identification were employed (between the mass ranges of 2000 to 20000 
Da).  The carbapenemases enzymes IMP-1, NDM-1 NDM-4, OXA-48 and VIM-2-
producing E. coli are best matched to E. coli DH5alpha, while KPC-2 and VIM-1 are best 
matched to E. coli MB11464 when analyzed on the current database of the Biotyper 
method.  In all cases, E. coli ATCC 25922 was the second or third best matched with a 
score of 2.3 to 2.4. 
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3.2 RESULTS OF CLINPROTOOLS ANALYSIS 
! 
Figure 1. Gel view comparing drug susceptible E. coli ATCC 25922 with other carbapenem resistant E. 
coli isolates producing different carbapenemases.  The gel view shows the raw spectra of all loaded spectra 
files arranged in a pseudo-gel like style.  The x-axis records the m/z value.  The left y-axis displays the 
running spectrum number initiating from subsequent spectra loading.  The peak intensity is expressed as a 
gray scale.  The color bar and the right y-axis indicate the relation between the color with which a peak is 
displayed and the peak intensity in arbitrary units. 
 
A virtual gel view representation of data derived from E. coli isolates is shown in (Fig.1).  
All individual spectra are shown on a density scale and this gel view shows the intensity 
distribution of the relevant signals in the different samples.  The common bands 
generated by these isolates appearing at 4364, 5383, 6256 and 6313 Da were used for 
normalization of spectra. 
 
The drug susceptible E. coli ATCC 25922 control strain was visually differentiated from 
the carbapenemase-producers bacteria and the most notable being the presence of bands 
at 4613 and 4769 Da, while there was an observed absence at 9063 and 9737 Da.  These 
two latter bands were also absent in the isolate carrying the resistant enzyme VIM-2, but 
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could be distinguished by a band at 5096 Da with a higher intensity that is common to the 
carbapenemase-producers E coli.  NDM-4 was identifiable by high intensity bands at 
6538 and 5755 Da.  IMP-1 exhibited a distinct band at 3673 Da that is present in all of 
the other isolates but with much lower intensities.  This procedure appears therefor to be 
capable of generating significantly different bands signals that may be employed in the 




Figure 2. Spectra of the selected carbapenem resistant E. coli isolates producing different carbapenemases 
compared with the drug susceptible E. coli ATCC 25922.. This Figure shows the generated spectra by the 
MALDI Biotyper method for each of the carbapenemase producing E. coli isolates compared to the 
sensitive ATCC 25922-type strain.  It describes the presence and absence of various peaks and their 
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5858; 7085; 7393; 7525 
*(I= Intensity, E= Exclusive, the designations for example, VIM-2 used here represent different classes of 
carbapenemases enzymes producing E. coli).   
 
Three groups of isolates were chosen randomly to investigate the significance of the mass 
peaks by their close or distant relationship.  ClinProTools provides a list of peaks selected 
according to statistical importance based on the intensity or the presence of one spectrum 
only, to differentiate between the selected isolates.  The visual peak picking was based on 
the presence of identifying exclusive peaks between spectra, and this enabled the 
detection of significant differences amongst E. coli isolates producing different 
carbapenemases (Table 2).  The comparison of drug susceptible E. coli ATCC 25922 and 
E. coli producing VIM-2 enzyme showed seven peaks distinctive to the standard strain 
while thirteen peaks unique to the carbapenemase-producing isolate.  Within the 
carbapenemase-producing isolates, we compared VIM-1 to KPC-2 and NDM-1 to OXA-
48 as an illustration.  Five peaks were matchless to KPC-2 and two to VIM-1 by 
visualization, while NDM-1 versus OXA-48 showed two and four exclusive peaks 
respectively.  
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Figure 3. Comparison of ClinProTools peak picking (left) versus the visual peak picking (right).  The 
ATCC 25922 type strain peaks are represented in red color and the carbapenemase producing VIM-2 in 
green color. 
 
In order to differentiate the selected isolates, the ClinProTools specified a list of peaks 
arranged according to the statistical significance where the notified distinction was the 
changes of intensity in general Fig. 3 (left).  Moreover the visual investigation was based 
only on the exclusive unique peaks Fig. 3 (right).  This figure illustrates the text in table 2 
showing presence/absence of peaks as well as differences in intensities among common 
peaks.   
 
3.3 RESULTS OF MALDI BIOTYPER 
We generated a main spectrum (MSP) of the standard control strain ensuring that the 
creation method included all of the peaks that were identified as exclusive between the 
species.  An MSP is the basic of classification using MALDI Biotyper.  It is a reference 
spectrum (normally an average of six to eight combined spectra) or more accurately a 
reference peak list that is assigned to a species or strain.  Subtyping MSPs are used to 
distinguish between closely related species.  In addition to extracting information on peak 
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frequency and peak intensity distribution, subtyping MSPs apply additional weighting to 
distinguish unique peaks.  The desired mass error for the MSP creation method was 
changed from 250 ppm to 2000 ppm and the desired peak number from 70 to 100.  The 
mass error of the raw spectra for the identification method was restricted to be 250 ppm 
as compared to the standard of 2000 ppm.  The modifications of the mass error were 
based on maximizing the inclusion of all relevant peaks.  VIM-2 was scanned against the 
existing Biotyper database to compare the standard methods with the modified version 
and, with the inclusion of the newly created MSP of the E. coli ATCC 25922- type strain.  
The standard identification method gave a score of 2.5 indicating a false positive for the 
species but modified version gave a score of 1.7.  Since the modified method represented 
a result closer to reality, these settings were used for the generation of the data in (Table 
3).  Database entries were created for all of the carbapenemase-producing E. coli with the 
new MSP creation method and found that this was warranted as more than 70 peaks were 
identified for each carbapenemase-producing isolate. 
 
Table 3. Evaluation of carbapenemase-producing E. coli isolates by the modified MSP* 
creation and identification methods. 
Isolates 
(Carbapenemase) First best matched Log (Score) 
Second best 
matched Log (Score) 
IMP-1 OXA-48 2.459 NDM-4 2.346 
KPC-2 VIM-1 2.482 NDM-1 2.270 
NDM-1 IMP-1 2.341 OXA-48 2.315 
NDM-4 OXA-48 2.383 IMP-1 2.352 
OXA-48 IMP-1 2.465 NDM-4 2.383 
VIM-1 KPC-2 2.482 E. coli DH5alpha 2.085 
VIM-2* IMP-1 2.129 E. coli RV412 2.043 
 
* Modifications of the mass error were based on maximizing the inclusion of all relevant peaks.  
*The designations for example VIM-2 used here represent different classes of carbapenemases enzymes 
producing E. coli.   
 
We scanned the carbapenemase-producers against the extended MSP database and 
ensured that the identification and MSP creation methods were matched to give full 
scores for the isolates against their own entries (score of 3.000).  The differences of 
scores between the first matched strains of the carbapenemase-producing E. coli were 
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0.518 to 0.871 and for the second matched strains were 0.617 to 0.957.  VIM-1 and VIM-
2, E. coli DH5 alpha and E. coli RV412 appeared as the second best matched with scores 
of 2.085 and 2.043 respectively, which are not considered as reliable in terms of strains 
identification.  We therefor attempted to find a more accurate method to analyze these 
isolates.  
4 DISCUSSION   
Different data analysis tools were employed for the optimization in this study.  The first 
phase of the analysis was the evaluation of the capacity of the MALDI Biotyper for 
isolate identification by MS profiling.  This was accurate with respect to genus and 
species.  Taking into consideration the advantages of this method of direct profiling, it is 
reasonable to conclude that it would be a potential tool for scientific and clinical 
laboratories studying various resistant E. coli strains provided that a significant difference 
in score is obtained between the analyzed isolates. 
 
The classification by the mathematical models revealed peaks responsible for 
differentiation between different carbapenemase-producing isolates.  However, it should 
be noted that while these models are very useful and rapid we could not totally rely on its 
analysis for the definitive identification of carbapenemases in E. coli based on results 
obtained.  The visual peak picking showed clearly that several peaks were not captured 
by the ClinProTools software because the algorithm based its differentiation on both the 
presence and intensity differences of the spectra, while the visualization based its 
selection criteria on the exclusivity of peaks. 
 
The second phase of this work was based on MSP creation method for carbapenemase 
detection.  Carbapenemase-producing isolates were identified using Biotyper with 
inclusion of the cellular organism of the Bruker database and the created assigned MSP.  
Enterobacteriales from the cellular organism and the new MSP were selected to identify 
all of the tested strains.  This method was able to give an improved difference between 
carbapenemase and non-carbapenemase producers, according to the score of best-
matched identities.  The first two best matched strains were mostly carbapenemase-
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producers, except for the VIM-1 and VIM-2 enzymes, where the second best matched 
strains were E. coli DH5alpha and E. coli RV412 with unreliable scores.  The 
significantly large difference in scores between isolates used for identification and the 
best matched indicates that a score above 2.5 could be used for “highly probable” sub-
species identification. 
 
Thus, based on our data, MALDI TOF MS has promising potential as a tool for rapid 
detection and diagnosis of carbapenemase-producing bacteria.  This potential can be 
further enhanced if the software would allow for manual weighting of the desired 
biomarker peaks.  Alternative, specific protein targets (biomarkers) can be used. 
 
We also recommend that a much broader collection of clinical isolates is used to 
understand the significance of these findings in a follow up study.  Subsequent studies 
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ABSTRACT  
Matrix-assisted laser desorption ionization time of flight mass spectrometry (MALDI-
TOF MS), a tool that has been recently introduced in routine diagnostic microbiology 
laboratories for the identification of bacterial and yeasts isolated from clinical samples, 
also has potential for the characterization of antimicrobial resistance, such as conferred 
by beta-lactamases.  In this study we investigated the capabilities of developing the 
MALDI-TOF MS based method as a rapid tool to characterize carbapenemase-producing 
enterobacteriaceae.  Different types of bacteria (Klebsiella pneumoniae, Enterobacter 
cloacae, Enterobacter asburiae, Serratia marcescens) carrying carbapenemases were 
involved in this investigation and subjected to optimized methods described in our 
previous work on carbapenem resistant Escherichia coli.  The characterization of 
carbapenemase-producing enterobacteriaceae using MALDI Biotyper MS based on the 
protein profiling appears promising by the visual observation of peaks that could be 
picked up from the MSP method by matchless low intensity peaks.  
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1 INTRODUCTION  
Mass spectrometry has been applied four decades ago to identify microorganisms (Anhalt 
& Fenselau, 1975; Bizzini, et al., 2010).  Recently, MALDI-TOF MS has been used for 
identification and a characterization method in many laboratories (Bailey, et al., 2013; 
Biswas & Rolain, 2013; Croxatto, Prod'hom, & Greub, 2012; L. Wang, et al., 2013), it 
has also proven its broad applicability in clinical epidemiology and infection control 
measures such as preventing dissemination of pathogens, medical diagnostics, 
environmental monitoring, bio-defense, and food quality control.  Consequently, this 
technology is widely utilized and has recently become popular for bacterial, fungal and 
yeast detection (Theel, 2013).  The short analysis time, accuracy, high sensitivity, 
minimal sample volume and large mass range (m/z) makes it a useful standard tool for 
bacterial identification (P. R. Murray, 2010). 
 
Drug resistance detection is the most desirable and recent application of MALDI-TOF 
MS in microbiology.  This assay has been described for characterization of drug resistant 
bacteria such as carbapenem-resistant enterobacteriaceae (CRE); various groups 
developed the method for the detection of the carbapenem antibiotics and their 
degradation products (Burckhardt & Zimmermann, 2011; Hrabak, Walkova, Studentova, 
Chudackova, & Bergerova, 2011; Sparbier, et al., 2012).  Beta-lactamases can be 
monitored by mass spectrometry profiling because hydrolysis of beta-lactams by 
resistance bacteria results in disappearance of the primary mass peak through a molecular 
mass shift of 18 Da of the drug; in some cases the hydrolysis is directly followed by 
decarboxylation of the hydrolyzed product, conducting in a further mass shift of 44 Da 
from the hydrolyzed form (Sparbier, et al., 2012). 
 
The spread of carbapenem-resistant bacteria, more specifically of carbapenemase-
producing Enterobacteriaceae and Acinetobacter baumannii, is a threat to worldwide 
healthcare and patient safety and as a result, the microbiologists over the globe pay 
special attention to carbapenemase-producing resistant bacteria, specifically Gram-
negative bacteria (Gupta, et al., 2011).  Therefore, carbapenemase-resistant 
enterobacteriaceae (CRE) have indeed become a scourge of public health, locally and 
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internationally, threatening the efficiency of all currently available antibiotics, save for 
colistin.  Recently the emergence of NDM-1 and KPC-2 for the first time in South Africa, 
has been documented among clinical isolates of Klebsiella pneumoniae and Enterobacter 
cloacae in hospitalized patients in Johannesburg and Pretoria (Brink, et al., 2012).  The 
Johannesburg and Cape Town Antimicrobial Resistance Reference Laboratories 
(AMRRL) of the Centre for Opportunistic, Tropical and Hospital Infections (COTHI) at 
National Institute of Communicable Diseases (NICD) of the National Health Laboratory 
Services (NHLS), since 2013, have been testing referred isolates of suspected 
carbapenemase-producing enterobacteriaceae for the presence of carbapenemase genes.  
The commonly referred isolates were K. pneumoniae (57/89, 64 %) and E. cloacae 
(22/89, 25 %).  Of all these isolates, 65 % tested positive for selected carbapenemase 
genes (Centre for Opportunistic, 2013).  There is thus a need for a rapid, accurate, 
sensitive and specific tool to detect these CRE.   
 
There are various techniques employed to detect carbapenem resistance, such as E-test 
(Jorgensen & Ferraro, 2009), modified Hodge test (MHT) (Amjad, et al., 2011; K. Lee, et 
al., 2010), 3-dimensional extract (3-D) bioassay (Montealegre, et al., 2012), 
Carbapenemase Nordmann-Poirel test (CarbaNPtest) (Nordmann, et al., 2012), 
spectrophotometry-based assay (Bernabeu, et al., 2012).  However, they are either 
dependent on phenotypic expression of the carbapenemases, time consuming or 
laborious, requiring much more technical skills.  They can also give false positive results 
(Carvalhaes, Picao, Nicoletti, Xavier, & Gales, 2010).  Genotype DNA/ RNA based PCR 
tests (Xia, et al., 2012) remains the gold standard for carbapenemase detection, it is a 
reliable method but expensive and become difficult to use with the increasing number of 
different types of carbapenemases (Poirel, et al., 2011). 
 
The present study expands on the existing work on bacterial identification to 
carbapenemase producing bacterial characterization by rapid detection tools.  Detection 
of methicillin resistant Staphylococcus aureus (MRSA) by MALDI-TOF MS based on 
protein profiling has been reported (Y. R. Wang, et al., 2013).  The application of this 
method to MALDI Biotyper as a conventional tool for biotyping of drug susceptibility 
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can solve the problem of the need for rapid point of care drug resistance diagnostics.  
Illustration of mass spectra obtained by the method of direct MS profiling can reflect not 
only species identity but also strain specificity of the analyzed mass spectra of 
enterobacteriaceae, as different strains carry various virulence and pathogenicity factors.   
 
The MALDI-TOF MS approach is quite easy to use, fast, relatively less laborious with 
significantly lesser consumable costs than traditional microbiological characterization 
methods (Seng, et al., 2009).  The aim of this study was to thus explore the potential of 
developing MALDI-TOF MS based method as a rapid tool to characterize 
carbapenemase-producing enterobacteriaceae. 
 
2 MATERIALS AND METHODS 
2.1 COLLECTION OF BACTERIAL STRAINS 
Bacterial isolates of Klebsiella pneumoniae, Enterobacter cloacae, Enterobacter 
asburiae and Serratia marcescens expressing different, well characterized 
carbapenemases, viz., KPC-2, KPC-3, GES-5, NMC-A, VIM-1, VIM-2, VIM-19, NDM-
1, IMP-1, IMP-8, IMP-11, SME-1, SME-2, OXA-48, OXA-181) belonging to the 
molecular classes A, B and D were purchased from France (Institut National de la Santé 
et de la Recherche Médicale, Paris, France).  This group had previously characterized 
these isolates for their beta-lactamase content at molecular level (Nordmann, et al., 2012) 
and susceptibility test have been carried out for all the strains used in this study by our 
group prior to go for MALDI approach.  Disc diffusion and broth dilution methods 
according CLSI guidelines were followed for this experiment.  E. coli ATCC (American 
Type Culture Collection) 25922 was used as the drug susceptible control.  The 
designations (for example IMP-1) used here represent different classes of 
carbapenemases enzymes.  All isolates were stored at -80 °C in tryptic soy broth with 
10% glycerol and recovered at 37 °C in Nutrient Agar medium prior to use.  Primary sub-
cultures were used for MALDI-TOF MS analysis.  Mass spectra were acquired in 
duplicate batches for each isolate. The same experiment has been repeated the following 
day for the reputability test. 
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2.2 PREPARATION OF THE INTACT BACTERIAL CELL 
All isolates were sub-cultured in Nutrient Agar medium (OXOID England) at 37 °C for 
24 h.  Fresh bacterial cells were transferred into protein LoBind tubes (eppendorf, 
Germany) containing sterile MilliQ water which was adjusted to an optical density of 
OD600 = 0.8, then 300 µL of this dilution was pipetted into a new eppendorf tubes and 
mixed with 900 µL of 100% ethanol (HPLC grade, Sigma Aldrich Germany).  The 
mixture was centrifuged at 13000 rpm for 2 minutes; the supernatant was decanted and 
centrifuged once again to remove the ethanol completely.  The pellet was re-suspended in 
50 µL of 70% formic acid and 50 µL of acetonitrile mixed carefully and centrifuged at 
13000 rpm for 2 minutes.  An aliquot of 1 µL of the supernatant was applied directly onto 
a cell of the MSP 96 target polished steel plate (Bruker Daltonics, Germany).  After 
drying for 1-2 minutes, 1 µL of the saturated matrix solution containing acetonitrile, 
trifluoroacetic acid and sterile MilliQ water (HPLC grade respectively) with α-4-cyano-
hydroxycinnamic acid (Bruker Daltonics, Germany) was applied onto the sample.  The 
prepared target was air dried prior to MALDI-TOF MS analysis.  Mass spectra were 
acquired in duplicate batches for each isolate. 
 
2.3 MASS SPECTROMETRY TESTS 
Mass spectra were acquired using a MALDI-TOF mass spectrometer (Bruker Daltonics) 
equipped with the nitrogen laser.  Spectra were registered in the linear mode of positive 
ions (20 kV) in the range of molecular masses 2000 - 20000 Dalton (Da).  The spectra 
were externally calibrated using the Bruker Bacterial Test Standard (BTS) obtained from 
Bruker Daltonics Germany containing a carefully manufactured extract of E. coli DH5 
alpha with two additional proteins that extend the upper boundary of the mass range 
covered by this calibrant mixture.  The increase of detection sensitivity was achieved by 
matrix excess removal by 6 laser impulses at 40% power output followed by subsequent 
data acquisition at laser power from 30-40%.  Each spectrum was acquired with 240 laser 
impulses (40 impulses with various spot points).  The spectra with resolution exceeding 
400 were acquired.  The programmed software (flexControl version 3.4 build 119, 
flexAnalysis version 3.4 build 70 and ClinProTools version 2.2 build 83) was employed 
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for acquiring, treatment, and analysis of mass spectra for differentiation of isolates at the 
strain level to differentiate drug resistant strains from the susceptible one investigated.  
This clustering version of mass spectra is an approach based on the use of algorithms of 
the ClinProTools software, which was initially developed for search of protein markers of 
various oncological diseases (Ketterlinus, et al., 2005; Qiu, et al., 2009).  Identification 
was performed using the MALDI Biotyper 3.1 software (Bruker Daltonics) by comparing 
experimental spectra with the reference library of the database containing 4613 spectra of 
various microorganisms.  Species identification was considered reliable, when the score 




3.1 MALDI BIOTYPER AND NEW MSP RESULTS   
 
Figure 1. MALDI-TOF mass spectra of S. marcescens IMP-1 (blue), K. pneumoniae IMP-1 (red), E. coli 
IMP-1 (green) and E. cloacae IMP-1 (pink) respectively. 
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Prepared samples from suspensions containing bacterial cells were grown on Nutrient 
Agar medium at 37 °C for 24 h.  The final product that contained protein was applied 
onto a target and α-4-cyano-hydroxycinnamic acid was employed as the matrix solution.  
The acquired spectra by MALDI Biotyper were analyzed by flexAnalysis version 3.4; the 
inclusion of E. coli above was based on the fact that it was used to optimize the method 
in our previous work.  Fig.1 shows the MALDI-TOF mass spectra of S. marcescens, K. 
pneumonia, E. cloacae and E. coli carrying IMP-1 enzyme illustrating the confidence of 
quality spectra obtained from the MALDI Biotyper (Table.1). 
 
Table.1. Carbapenemase-producing enterobacteriaceae used in the study and their 
MALDI Biotyper scores for the standard MSP methods. 
First best match Score Second best match Score
K. pneumoniae IMP-1 K. pneumoniae ssp pneumoniae 9295 CHB 2.369 K. pneumoniae RV_BA_03_B LBK 2.274
K. pneumoniae IMP-8 K. pneumoniae ssp pneumoniae 9295 CHB 2.476 K. pneumoniae RV_BA_03_B LBK 2.423
K. pneumoniae KPC-2 K. pneumoniae ssp pneumoniae 9295 CHB 2.613 K. pneumoniae RV_BA_03_B LBK 2.582
K. pneumoniae KPC-3 K. pneumoniae ssp pneumoniae 9295 CHB 2.601 K. pneumoniae RV_BA_03_B LBK 2.589
K. pneumoniae NDM-1 K. pneumoniae RV_BA_03_BLBK 2.197 K. pneumonia ssp rhinoscleromatis DSM 2.093
K. pneumoniae OXA-181 K. pneumoniae ssp pneumoniae DSM 2.485 K. pneumoniae RV_BA_03_B LBK 2.413
K. pneumoniae OXA-48 K. pneumoniae ssp pneumoniae 9295 CHB 2.598 K. pneumoniae RV_BA_03_B LBK 2.569
K. pneumoniae VIM-1 K. pneumoniae ssp pneumoniae 9295 CHB 2.558 K. pneumoniae 37585 PFM 2.497
K. pneumoniae VIM-19 K. pneumoniae RV_BA_03_BLBK 2.387 K. pneumoniae ssp ozaenae DSM 16358T 2.368
E. cloacae KPC-2 E. cloacae MB 11506_1 CHB 2.413 E. cloacae MB_5277_05 THL 2.373
E. cloacae NDM-1 E. cloacae MB 11506_1 CHB 2.491 E. cloacae 13159_1 CHB 2.442
E. cloacae IMP-8 E. cloacae MB 11506_1 CHB 2.145 E. cloacae MB_8779_05 THL 2.120
E. cloacae OXA-48 E. cloacae MB 11506_1 CHB 2.520 E. cloacae 13159_1 CHB 2.379
E. asburiae VIM-1 E. asburiae CCM 4032 CCM 2.357 E. asburiae DSM 17506T DSM 2.238
E. asburiae GES-5 E. asburiae CCM 4032 CCM 2.369 E. asburiae RV412_A1_2010_05 LBK 2.276
E. cloacae IMP-1 E. cloacae 13159_1 CHB 2.414 E. cloacae MB11506_1 CHB 2.367
E. asburiae NMC-A E. asburiae DSM 17506T DSM 2.274 E. asburiae RV412_A1_2010_05 LBK 2.230
S. marcescens IMP-1 S. marcescens 13103_1 CHB 2.478 S. marcescens ssp marcescens DSM 2.452
S. marcescens IMP-11 S. marcescens 13103_1 CHB 2.382 S. marcescens ssp marcescens DSM 2.339
S. marcescens KPC-2 S. marcescens DSM 12485 DSM 2.460 S. marcescens ssp marcescens DSM 2.441
S. marcescens SME-1 S. marcescens 13103_1 CHB 2.402 S. marcescens ssp marcescens DSM 2.378
S. marcescens SME-2 S. marcescens ssp marcescens DSM 30121T DSM 2.361 S. marcescens 13103_1 CHB 2.350
S. marcescens VIM-2 S. marcescens 13103_1 CHB 2.363 S. marcescens DSM 30122 DSM 2.359
Strains
MALDI Biotyper MS profiling
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The selected isolates for this study were identified using MALDI Biotyper software and 
compared with the reference library of the database that contains 4613 spectra of various 
microorganisms only.  They were reliably classified with confident scores (Table.1).  The 
MALDI Biotyper result confirmed the previous identity of all the isolates.  Values 
between 2.000 to 2.299 shows that the isolate has secured genus identification and a 
probable species identification, while 2.300 to 3.000 gives highly probable species 
identification.  Most of the K. pneumoniae strains were matched to K. pneumonia ssp. 
pneumonia 9295 CHB strain in the reference library, the E. cloacae to E. cloacae MB 
11506_1 CHB and S. marcescens to S. marcescens 13103_1 CHB.  The scores were, in 
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Table.2. Comparative results of the standard and modified MSP methods for 
carbapenemase-producing enterobacteriaceae with the extended database. 
First best match Score First best match Score
K. pneumoniae IMP-1 K. pneumoniae IMP-8 2.376 K. pneumoniae VIM-1 2.210
K. pneumoniae IMP-8 K. pneumoniae ssp pneumoniae 9295 CHB 2.435 K. pneumoniae OXA-181 1.438
K. pneumoniae KPC-2 k. pneumoniae  OXA-48 2.659 k. pneumoniae  OXA-48 2.630
K. pneumoniae KPC-3 k. pneumoniae  OXA-48 2.708 k. pneumoniae  OXA-48 2.512
K. pneumoniae NDM-1 k. pneumoniae  VIM-19 2.232 k. pneumoniae  VIM-19 1.814
K. pneumoniae OXA-181 k. pneumoniae  VIM-19 2.568 k. pneumoniae  KPC3 2.487
K. pneumoniae OXA-48 k. pneumoniae  KPC-2 2.722 k. pneumoniae KPC-2 2.645
K. pneumoniae VIM-1 k. pneumoniae  KPC-2 2.613 k. pneumoniae  KPC-2 2.523
K. pneumoniae VIM-19 k. pneumoniae  OXA-181 2.645 k. pneumoniae  OXA-181 2.219
E. cloacae KPC-2 E. cloacae MB 5277 05 THL 2.412 E. cloacae OXA-48 1.709
E. cloacae NDM-1 E. cloacae OXA-48 2.589 E. cloacae OXA-48 2.516
E. cloacae IMP-8  E. cloacae IMP-1 2.085 E. cloacae IMP-1 2.006
E. cloacae IMP-1 E. cloacae NDM-1 2.489 E. cloacae NDM-1 2.204
E. cloacae OXA-48 E. cloacae NDM-1 2.683 E. cloacae NDM-1 2.563
E. asburiae VIM-1 E. asburiae GES-5 2.476 E. asburiae GES-5 2.298
E. asburiae GES-5 E. asburiae VIM-1 2.471 E. asburiae VIM-1 2.298
E. asburiae NMC-A E. asburiae VIM-1 2.328 E. asburiae GES-5 2.104
S. marcescens IMP-1 S. marcescens VIM-2 2.468 S. marcescens VIM-2 2.418
S. marcescens IMP-11 S. marcescens SME-2 2.573 S. marcescens SME-2 2.274
S. marcescens KPC-2 S. marcescens SME-2 2.523 S. marcescens VIM-2 2.173
S. marcescens SME-1 S. marcescens SME-2 2.563 S. marcescens SME-2 2.538
S. marcescens SME-2 S. marcescens SME-1 2.581 S. marcescens SME-1 2.538
S. marcescens VIM-2 S. marcescens IMP-1 2.501 S. marcescens IMP-1 2.418
Strains
Bruker standard MSP Modfied MSP
 
 
The selected isolates were identified using the extended reference library that now 
contains the CREs from this study.  The MSP of the isolate to be identified was excluded 
from the taxonomy after confirming that it gave a score of three for several runs with the 
optimized methods.  The standard MSP creation and identification methods were in most 
cases able to match the CREs with at least one of the other carbapenemase producing 
enterobacteriaceae with high confidence to the species.  Our previous work on 
carbapenemase producing E. coli has led to an optimization of the MSP creation and 
identification methods for gaining maximum inclusion of all relevant peaks, being the 
reason that the desired mass error for the MSP creation method was optimized from 250 
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ppm to 2000 ppm and the desired peak number from 70 to 100.  The mass error of the 
raw spectra for the identification method was restricted to be 250 ppm as compared to the 
standard of 2000 ppm, the lower bound was extended from 3000 to 2000 and the upper 
bound from 15000 to 20000.  All of the isolates of this study were included onto the 
existing MALDI Biotyper database that was subsequently used for identification.  In the 
cases where the standard MSP methods were identified as non-CRE, there was no 
ambiguity with this approach.  This is clearly illustrated by results obtained for K. 
pneumoniae IMP-1 and IMP-8, and E. cloacae KPC-2 and IMP-8 strains.  The scores for 
the best-matched strains showed an overall decrease with most of the values being below 
2.5 with exception to K. pneumoniae producing KPC-2, KPC-3, OXA-48 and VIM-1.  In 
our previous study we concluded that it might be possible to get strain identification if the 
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3.2 RESULTS OF CLINPROTOOLS ANALYSIS 
 
Figure 2. Gel view comparing carbapenem resistant isolates expressing different enzymes.  The gel view 
shows the raw spectra of all loaded spectra files arranged in a pseudo-gel like style.  The x-axis records the 
m/z value while the left y-axis displays the running spectrum number initiating from subsequent spectra 
loading.  The peak intensity is expressed by a rainbow scale scheme code.  The color bar and the right y-
axis indicate the relation between the color with which a peak is displayed and the peak intensity in 
arbitrary units. 
 
The gel view representation of the acquired spectra from K. pneumoniae, E. asburiae, E. 
cloacae, and S. marcescens are shown in (Fig.2).  All individual spectra are shown on a 
density scale and this gel view shows the intensity distribution of the relevant signals in 
the different samples.  In each group of bacteria common bands were observed, at 7706 
Da for K. pneumoniae, 7890 Da for S. marcescens, 7068 Da for E. asburiae and at 5474 
Da for E. cloacae.   
 
Within carbapenemase-producing K. pneumoniae distinguishable bands could be 
observed at 3060 Da with high intensity level for VIM-19 that was also present in NDM-
1 and VIM-1 but easily separable by the presence of bands at 2505 Da for NDM-1 and 
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with a low intensity bands at 6450 Da in VIM-1.  IMP-1 and IMP-8 were identifiable by 
the presence of bands at 8209 and 3843 Da in IMP-1.  KPC-2 and KPC-3 exhibited a 
distinct band at 6011 Da.  OXA-48 and OXA-181 could be distinguished at 5977 Da.   
 
Specific bands could also be observed in the group of E. asburiae at 4685 and 2318 Da 
for GES-5, 2469 and 3392 Da for VIM-1.  NMC-A was distinguishable by the presence 
of tinny bands at 10794 Da.  In the group of E. cloacae, OXA-48 is observable by the 
band at 6484 Da, IMP-1 at 5993 Da, KPC-2 with a thin band at 8511 and NDM-1 at 
10290 Da having low intensity.   
 
S. marcescens carrying VIM-2 and IMP-1 enzyme were distinguishable by the bands at 
15854 Da from others, and a particular band at 2015 Da, a tinny band also appeared at 
1584 Da and absence of band at 9974 Da with IMP-11.  Four consecutives bands were 
observable at 3046, 3112, 3177 Da for KPC-2.  The differences between SME-1 and 
SME-2 could be observed at 6830 and 7501 Da.  This procedure appears to be capable of 
generating significantly different bands signals that may be optimized and included in the 
differentiation of these isolates. 
 
 
Figure 3. Comparative visual inspection of typical spectra for the standard and modified MSP methods 
showing distinctive low intensity peaks.  Spectra of K. pneumoniae OXA-48 for the standard methods (left) 
and spectra of the same K. pneumoniae OXA-48 for the modified MSP methods (right).  The visualization 
of peaks between the two methods revealed differences in terms of intensity and exclusivity.  The standard 
method illustrates the matchless low intensity peaks and the modified method revealed that these 
significant peaks must be taken into account in the algorithm to make differences between the carbapenem-
resistant enterobacteriaceae. 
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The inspection view (Figure 3) displays the graphical output of identification results 
obtained by comparing a loaded spectra or MSP (green and red) to be identified with a 
MSP used for characterization (blue).  The upper part shows the adjusted normalized 
peak list of the unknown isolates spectra while the lower part represents the peaks list of 
the MSP used for identification that is selected in the MSP scores for biotyping.  The x-
axis records the m/z value (103) and the y-axis the relative peak intensity.  The result of 
matching the peaks of the unknown isolates spectra MSP to be identified with those of 
the MSP used for identification is expressed by a traffic light coloring of the peaks of the 
unknown isolates spectra MSP.  Peaks matching within the inner window (full match) 
were displayed in green, peaks matching within the outer window (partial match) in 
yellow and non-matching peaks in red.  The standard MSP method used in our study 
showed more matchless low intensity peaks compared to the modified MSP method this 
suggest that differences between CRE producing different carbapenemases can be 
discriminated by consideration of these significant peaks in the algorithm. 
 
4 CONCLUSION 
The differentiation of carbapenemase-producing enterobacteriaceae remains a challenge 
using MALDI Biotyper MS based on the protein profiling due to the close relationship 
between the carbapenemases and the Enterobacteriaceae.  The overall aim was to get the 
scores below 2.5 to leave enough room to develop the database to accommodate such 
these strains.  The visual observation of peaks demonstrated that the differences within 
the carbapenemases could be improved with the modified MSP methods by focusing on 
matchless low intensity peaks since the non-consideration of these peaks resulted in less 
significant scores.  While many biomarker peaks may be identified, the software would 
need to allow for the user to determine the weighting of the peak and therefore its 
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CHAPTER 4 
CONCLUSION 
This study attempted to evaluate the potential of MALDI-TOF mass spectrometry 
Biotyper technology to discriminate between carbapenem-resistant enterobacteriaceae 
expressing a range of carbapenemases belonging to different Ambler classes.  According 
to the data we found this tool to be promising as an accurate and rapid method for 
detection and diagnosis of carbapenemase-producing bacteria.  This potential can be 
further enhanced if the software would allow for manual weighting of the desired 
biomarker peaks.  Alternative, specific protein targets (biomarkers) can be also used.  
  
We strongly recommend that a much broader collection of clinical isolates be tested in 
order to understand the significance of these findings in a follow up study.  Subsequent 
studies should also identify the unique proteins observed for different isolates.   
 
 
 
